Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Grazoprevir (MK-5172)+ Elbasvir (MK-8742) for the Treatment of Acute Hepatitis C Genotype 1/4. The Dutch Acute HCV in HIV Study (DAHHS-2)

NCT02600325 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT02600325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02600325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Grazoprevir (MK-5172)+ Elbasvir (MK-8742) for the Treatment of Acute Hepatitis C Genotype 1/4. The Dutch Acute HCV in HIV Study (DAHHS-2)
Lead sponsor
Erasmus Medical Center
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2016
Completion date
January 11, 2019
Enrollment
80 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acute hepatitis c, hepatitis c, human immunodeficiency virus